Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Abbott, Alere, Roche, and Others Receive FDA Clearances in May

Abbott, Alere, Roche, and Others Receive FDA Clearances in May

Jun 08, 2018
|
staff reporter

NEW YORK (360Dx) – Abbott, its subsidiary Alere, and Roche were among companies that received US Food and Drug Administration clearances in May for their in vitro diagnostic tests, according to the FDA website.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Infectious Disease

  1. U of Oxford Develops Five-Minute, Single-Particle Test to Detect SARS-CoV-2, Respiratory Infections

    Premium

  2. Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test

  3. Interleukin Biomarkers Could Help Determine Severity of COVID-19, According to New Study

    Premium

  4. Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company

  5. Credo Diagnostics Combo Influenza, COVID-19 Test Receives CE-IVD Mark

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.